MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma

por Gubbi, Sriram, Al-Jundi, Mohammad, Jha, Abhishek, Knue, Marianne, Zou, Joy, Rivero, Jaydira Del, Turkbey, Baris, Carrasquillo, Jorge A, Pacak, Karel, Klubo-Gwiezdzinska, Joanna, Lin, Frank I
Publicado 2020

SAT-502 Clinical Hypothyroidism Associated with Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma: A Novel Adverse Effect of Peptide Receptor Radionuclide Therapy

por Gubbi, Sriram, Al-Jundi, Mohammad, Jha, Abhishek, Knue, Marianne, Zou, Joy, Rivero, Jaydira Del, Turkbey, Baris, Carrasquillo, Jorge A, Pacak, Karel, Klubo-Gwiezdzinska, Joanna, Lin, Frank I
Publicado 2020

Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

por Gubbi, Sriram, Al-Jundi, Mohammad, Del Rivero, Jaydira, Jha, Abhishek, Knue, Marianne, Zou, Joy, Turkbey, Baris, Carrasquillo, Jorge Amilcar, Lin, Emily, Pacak, Karel, Klubo-Gwiezdzinska, Joanna, Lin, Frank I-Kai
Publicado 2021

Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [(177)Lu]Lu-DOTA-TATE therapy

por Gubbi, Sriram, Al-Jundi, Mohammad, Auh, Sungyoung, Jha, Abhishek, Zou, Joy, Shamis, Inna, Meuter, Leah, Knue, Marianne, Turkbey, Baris, Lindenberg, Liza, Mena, Esther, Carrasquillo, Jorge A., Teng, Yating, Pacak, Karel, Klubo-Gwiezdzinska, Joanna, Del Rivero, Jaydira, Lin, Frank I.
Publicado 2023